102 reports of this reaction
4.7% of all FLUMAZENIL reports
#1 most reported adverse reaction
INTENTIONAL OVERDOSE is the #1 most commonly reported adverse reaction for FLUMAZENIL, manufactured by Baxter Healthcare Corporation. There are 102 FDA adverse event reports linking FLUMAZENIL to INTENTIONAL OVERDOSE. This represents approximately 4.7% of all 2,155 adverse event reports for this drug.
Patients taking FLUMAZENIL who experience intentional overdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INTENTIONAL OVERDOSE is moderately reported among FLUMAZENIL users, representing a notable but not dominant share of adverse events.
In addition to intentional overdose, the following adverse reactions have been reported for FLUMAZENIL:
The following drugs have also been linked to intentional overdose in FDA adverse event reports:
INTENTIONAL OVERDOSE has been reported as an adverse event in 102 FDA reports for FLUMAZENIL. This does not prove causation, but indicates an association observed in post-market surveillance data.
INTENTIONAL OVERDOSE accounts for approximately 4.7% of all adverse event reports for FLUMAZENIL, making it one of the most commonly reported side effect.
If you experience intentional overdose while taking FLUMAZENIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.